Internal Medicine · Los Angeles, CA
NPI
1770926263
Since 2013
Specialty
Internal Medicine
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1200 N State St
Los Angeles, CA, 90033
Phone (323) 226-7556
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,814
28 services
Medicare patients, 2024
16
Average age 67
Drug cost, 2024
$1.3M
4,381 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Zachary D Perez prescribed most often to Medicare patients was Ozempic (Semaglutide), with 557 prescriptions and refills. In total Zachary D Perez wrote 4,381 Medicare prescriptions that cost $1.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 557 | 642 | 86 | $445K |
| Levothyroxine Sodium Generic | 339 | 1,109 | 121 | $6,367 |
| Insulin Glargine-Yfgn Generic | 287 | 761 | 99 | $36K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 270 | 643 | 115 | $8,143 |
| Glipizide Generic | 222 | 669 | 88 | $2,631 |
| Jardiance Empagliflozin | 216 | 681 | 80 | $137K |
| Methimazole Generic | 178 | 567 | 62 | $3,487 |
| Metformin Hcl Er Metformin Hcl | 170 | 564 | 70 | $1,570 |
| Alendronate Sodium Generic | 165 | 458 | 55 | $1,644 |
| Metformin Hcl Generic | 146 | 481 | 48 | $1,878 |
| Mounjaro Tirzepatide | 138 | 140 | 23 | $156K |
| Humalog Kwikpen U-100 Insulin Lispro | 109 | 293 | 45 | $43K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 95 | 241 | 37 | $18K |
| Atorvastatin Calcium Generic | 93 | 309 | 38 | $1,163 |
| Humalog Insulin Lispro | 64 | 192 | 22 | $25K |
Brand drugs: 1,916 claims; generic drugs: 1,990 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Zachary D Perez were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.